BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33086191)

  • 1. PDK2-enhanced glycolysis promotes fibroblast proliferation in thyroid-associated ophthalmopathy.
    Ma R; Gan L; Ren H; Harrison A; Qian J
    J Mol Endocrinol; 2020 Nov; 65(4):163-174. PubMed ID: 33086191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PH20 Inhibits TGFβ1-Induced Differentiation of Perimysial Orbital Fibroblasts via Hyaluronan-CD44 Pathway in Thyroid-Associated Ophthalmopathy.
    Ma R; Ren H; Xu B; Cheng Y; Gan L; Zhang R; Wu J; Qian J
    Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1431-1441. PubMed ID: 30947333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights Into Ferroptosis: Targeting Glycolysis to Treat Graves' Orbitopathy.
    Ma R; Gan L; Guo J; Peng Z; Wu J; Harrison AR; Qian J
    J Clin Endocrinol Metab; 2022 Jun; 107(7):1994-2003. PubMed ID: 35303084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-17A Promotes RANTES Expression, But Not IL-16, in Orbital Fibroblasts Via CD40-CD40L Combination in Thyroid-Associated Ophthalmopathy.
    Fang S; Huang Y; Zhong S; Zhang Y; Liu X; Wang Y; Gu P; Zhou H; Fan X
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6123-6133. PubMed ID: 27832278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Prunella vulgaris polysaccharides on cultured orbit fibroblasts in vitro from patients with thyroid-associated ophthalmopathy.
    Li B; Guo J; Wang F; Cheng S; Zeng L
    Exp Eye Res; 2020 Dec; 201():108276. PubMed ID: 32991886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy.
    Tong BD; Xiao MY; Zeng JX; Xiong W
    Mol Vis; 2015; 21():324-34. PubMed ID: 25873777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid induces COX-2 expression via CD44 in orbital fibroblasts from patients with thyroid-associated ophthalmopathy.
    Lim HS; Back KO; Kim HJ; Choi YH; Park YM; Kook KH
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7441-50. PubMed ID: 25342622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects and Its Mechanism of IGF-1R on the Synthesis of Hyaluronic Acid in Orbital Fibroblasts of Thyroid Associated Ophthalmopathy].
    Chen XL; He WM; Li W
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 48(5):727-731. PubMed ID: 29130665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy.
    Song D; Wang R; Zhong Y; Li W; Li H; Dong F
    Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):433-40. PubMed ID: 22159761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial pyruvate dehydrogenase kinases contribute to platelet function and thrombosis in mice by regulating aerobic glycolysis.
    Flora GD; Nayak MK; Ghatge M; Kumskova M; Patel RB; Chauhan AK
    Blood Adv; 2023 Jun; 7(11):2347-2359. PubMed ID: 36971790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 enhances the expression of functional TSH receptor in orbital fibroblasts from thyroid-associated ophthalmopathy.
    Paik JS; Kim SE; Kim JH; Lee JY; Yang SW; Lee SB
    Immunobiology; 2020 Mar; 225(2):151902. PubMed ID: 31899052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide inhibits secretion of IGF-1 from orbital fibroblasts in patients with thyroid-associated ophthalmopathy via inhibition of the NF-κB pathway.
    Kim SE; Kim J; Lee JY; Lee SB; Paik JS; Yang SW
    PLoS One; 2021; 16(4):e0249988. PubMed ID: 33886620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disulfiram Exerts Antifibrotic and Anti-Inflammatory Therapeutic Effects on Perimysial Orbital Fibroblasts in Graves' Orbitopathy.
    Wang X; Ye H; Yang S; Sha X; Wang X; Zhang T; Chen R; Xiao W; Yang H
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy.
    Pan Y; Wang M; Chen X; Chen Y; Ai S; Wang M; Su W; Liang D
    Int Immunopharmacol; 2021 Feb; 91():107300. PubMed ID: 33383445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic Profiling of Control and Thyroid-Associated Orbitopathy (TAO) Orbital Fat and TAO Orbital Fibroblasts Undergoing Adipogenesis.
    Kim DW; Taneja K; Hoang T; Santiago CP; McCulley TJ; Merbs SL; Mahoney NR; Blackshaw S; Rajaii F
    Invest Ophthalmol Vis Sci; 2021 Jul; 62(9):24. PubMed ID: 34269815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.
    Diao J; Chen X; Mou P; Ma X; Wei R
    Invest Ophthalmol Vis Sci; 2022 Sep; 63(10):6. PubMed ID: 36094643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of CCR1 in the orbital fibroblasts with thyroid associated ophthalmopathy].
    Liu CL; Zhang XJ; Guo B; Yang JF; Luo QL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 42(5):630-2. PubMed ID: 22007486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy.
    Zhao P; Deng Y; Gu P; Wang Y; Zhou H; Hu Y; Chen P; Fan X
    Exp Eye Res; 2013 Feb; 107():65-73. PubMed ID: 23219871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts.
    Wei L; Huang Q; Tu Y; Song S; Zhang X; Yu B; Liu Y; Li Z; Huang Q; Chen L; Liu B; Xu S; Li T; Liu X; Hu X; Liu W; Chi ZL; Wu W
    J Transl Med; 2024 Jun; 22(1):546. PubMed ID: 38849907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy.
    Tomlinson JW; Durrani OM; Bujalska IJ; Gathercole LL; Tomlins PJ; Reuser TT; Rose GE; Curnow SJ; Stewart PM; Walker EA; Rauz S
    J Clin Endocrinol Metab; 2010 Jan; 95(1):398-406. PubMed ID: 19880789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.